Prevalence of long-term opioid therapy in a chronic non-cancer pain population attending a university-based tertiary pain clinic in Sweden. A cross-sectional study
(2022) In Journal of Rehabilitation Medicine 54.- Abstract
BACKGROUND: Opioid therapy has become a common treatment for chronic pain despite accumulating evidence regarding harm and the lack of data to support efficacy for long-term treatments. The prevalence of opioid treatments in Swedish patients with chronic non-cancer pain is unknown. Hence, the present study aimed to assess a short-term period prevalence of prescribed opioid-use and long-term opioid therapy (LTOT) in a population with complex chronic non-cancer pain.
METHOD: The study population consisted of 1613 patients suffering from chronic non-cancer pain and referred to a university-based tertiary pain clinic in Sweden during 2015-2017. Data from a 360-day period prior to consultation were extracted from the Swedish Quality... (More)
BACKGROUND: Opioid therapy has become a common treatment for chronic pain despite accumulating evidence regarding harm and the lack of data to support efficacy for long-term treatments. The prevalence of opioid treatments in Swedish patients with chronic non-cancer pain is unknown. Hence, the present study aimed to assess a short-term period prevalence of prescribed opioid-use and long-term opioid therapy (LTOT) in a population with complex chronic non-cancer pain.
METHOD: The study population consisted of 1613 patients suffering from chronic non-cancer pain and referred to a university-based tertiary pain clinic in Sweden during 2015-2017. Data from a 360-day period prior to consultation were extracted from the Swedish Quality Registry for Pain Rehabilitation (SQRP) and Swedish Prescribed Drug Register (SPDR). Milligram morphine equivalents per day (MME/day) for dispensed opioids were analysed for a 90-day period preceding consultation and long-term opioid therapy (LTOT) was determined for the entire 360-day period.
RESULTS: The 90-day prevalence was 38% (CI 36-40,8) and the 360-day prevalence was 22.3% (n=360 with CI 20.4-24.4).
CONCLUSION: The prescribing rates of opioids in a Swedish population with complex non-cancer chronic pain were high; two in five patients were dispensed an opioid within a 90-day period prior to consultation.
(Less)
- author
- Grelz, Henrik LU ; Fischer, Marcelo Rivano LU ; Priouzifard, Mirnabi ; Midlöv, Patrik LU and Ringqvist, Åsa LU
- organization
- publishing date
- 2022-04-29
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Rehabilitation Medicine
- volume
- 54
- article number
- jrm00270
- publisher
- Taylor & Francis
- external identifiers
-
- scopus:85129781189
- pmid:35174866
- ISSN
- 1651-2081
- DOI
- 10.2340/jrm.v54.1981
- language
- English
- LU publication?
- yes
- id
- 8ea6ccfc-d742-44f9-b25b-ca9d44fb26df
- date added to LUP
- 2022-03-17 12:11:19
- date last changed
- 2024-06-27 06:54:01
@article{8ea6ccfc-d742-44f9-b25b-ca9d44fb26df, abstract = {{<p>BACKGROUND: Opioid therapy has become a common treatment for chronic pain despite accumulating evidence regarding harm and the lack of data to support efficacy for long-term treatments. The prevalence of opioid treatments in Swedish patients with chronic non-cancer pain is unknown. Hence, the present study aimed to assess a short-term period prevalence of prescribed opioid-use and long-term opioid therapy (LTOT) in a population with complex chronic non-cancer pain.</p><p>METHOD: The study population consisted of 1613 patients suffering from chronic non-cancer pain and referred to a university-based tertiary pain clinic in Sweden during 2015-2017. Data from a 360-day period prior to consultation were extracted from the Swedish Quality Registry for Pain Rehabilitation (SQRP) and Swedish Prescribed Drug Register (SPDR). Milligram morphine equivalents per day (MME/day) for dispensed opioids were analysed for a 90-day period preceding consultation and long-term opioid therapy (LTOT) was determined for the entire 360-day period.</p><p>RESULTS: The 90-day prevalence was 38% (CI 36-40,8) and the 360-day prevalence was 22.3% (n=360 with CI 20.4-24.4).</p><p>CONCLUSION: The prescribing rates of opioids in a Swedish population with complex non-cancer chronic pain were high; two in five patients were dispensed an opioid within a 90-day period prior to consultation.</p>}}, author = {{Grelz, Henrik and Fischer, Marcelo Rivano and Priouzifard, Mirnabi and Midlöv, Patrik and Ringqvist, Åsa}}, issn = {{1651-2081}}, language = {{eng}}, month = {{04}}, publisher = {{Taylor & Francis}}, series = {{Journal of Rehabilitation Medicine}}, title = {{Prevalence of long-term opioid therapy in a chronic non-cancer pain population attending a university-based tertiary pain clinic in Sweden. A cross-sectional study}}, url = {{http://dx.doi.org/10.2340/jrm.v54.1981}}, doi = {{10.2340/jrm.v54.1981}}, volume = {{54}}, year = {{2022}}, }